Prenetics is a Personalized & Precision Medicine Life Sciences company specializing in Pharmacogenomics. Prenetics proprietary iGenes test enables physicians to identify in patients the right drug, right dosage and to list out potential adverse drug reactions, based on one's genetic profile. Prenetics vision is to improve quality of life, prevent ADR's and to save on healthcare costs by providing the tools essential for personalized medication management.
TypePrivate
HQHong Kong, HK
Founded2009
Size (employees)64 (est)-5%
Websiteprenetics.com
Prenetics was founded in 2009 and is headquartered in Hong Kong, HK
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Prenetics

Danny Yeung

Danny Yeung

CEO

Prenetics Office Locations

Prenetics has an office in Hong Kong
Hong Kong, HK (HQ)
Queen's Road Central
Show all (1)
Report incorrect company information

Prenetics Financials and Metrics

Summary Metrics

Founding Date

2009

Prenetics total Funding

$52.7 m

Prenetics latest funding size

$40 m

Time since last funding

a year ago

Prenetics investors

Prenetics's latest funding round in October 2017 was reported to be $40 m. In total, Prenetics has raised $52.7 m
Show all financial metrics
Report incorrect company information

Prenetics Online and Social Media Presence

Embed Graph
Report incorrect company information

Prenetics News and Updates

Nutrigenomics Market Strategies and Competitive Analysis Managed to Grow with CAGR of 16.8% by Products, Techniques and Application till 2023

Market Research Future has released a new report on the Global Nutrigenomics Market which reveals a notable CAGR of 16.8% during the forecast period of 2017 to 2023 with an estimated value of USD 4,860.2 million by the end of 2023. Posted via Industry Today. Follow us on Twitter @IndustryToday

Genetics testing startup Prenetics buys UK’s DNAFit to move into consumer services

Prenetics, a Hong Kong-based startup that offers genetic testing services for patients, is expanding outside of Asia and into the consumer space after it acquired London-based company DNAFit. The deal — which a source told TechCrunch is worth $10 million — not only sees Prenetics enter new geographi…

Alibaba-backed Prenetics acquires UK genetic testing firm DNAFit

Hong Kong-based genetic testing company Prenetics has acquired DNAFit, a British DNA testing company. With over $50m (£34.8m) in funding from Chinese retail giant Alibaba and Ping An Insurance, this is Prenetics' first acquisition. The sale marks a further expansion into the UK market by Prenetic…
Report incorrect company information

Prenetics Company Life and Culture

Report incorrect company information